Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemical Diversity in the G Protein-Coupled Receptor Superfamily
Márton Vass, Albert J. Kooistra, Dehua Yang, et al.
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 5, pp. 494-512
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Common activation mechanism of class A GPCRs
Qingtong Zhou, Dehua Yang, Meng Wu, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 522
Impact of GPCR Structures on Drug Discovery
Miles Congreve, Chris de Graaf, Nigel A. Swain, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 81-91
Open Access | Times Cited: 299
Advances in therapeutic peptides targeting G protein-coupled receptors
Anthony P. Davenport, Conor C. G. Scully, Chris de Graaf, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 6, pp. 389-413
Open Access | Times Cited: 222
GPCRomics: An Approach to Discover GPCR Drug Targets
Paul A. Insel, Krishna Sriram, Matthew W. Gorr, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 6, pp. 378-387
Open Access | Times Cited: 156
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 340-372
Open Access | Times Cited: 105
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders
Rexhina Vlashi, Xingen Zhang, Mengrui Wu, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1291-1317
Open Access | Times Cited: 78
KLIFS: an overhaul after the first 5 years of supporting kinase research
Georgi K. Kanev, Chris de Graaf, Bart A. Westerman, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D562-D569
Open Access | Times Cited: 125
New Binding Sites, New Opportunities for GPCR Drug Discovery
H. C. Stephen Chan, Yi Li, Thamani Dahoun, et al.
Trends in Biochemical Sciences (2019) Vol. 44, Iss. 4, pp. 312-330
Open Access | Times Cited: 123
Ligand binding at the protein–lipid interface: strategic considerations for drug design
Jian Payandeh, Matthew Volgraf
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 710-722
Closed Access | Times Cited: 88
Revealing Unexplored Sequence-Function Space Using Sequence Similarity Networks
Janine N. Copp, Eyal Akiva, Patricia C. Babbitt, et al.
Biochemistry (2018) Vol. 57, Iss. 31, pp. 4651-4662
Open Access | Times Cited: 83
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates
Hongchuan Jin, Hui Chen, Li Xie, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 7, pp. 1321-1336
Closed Access | Times Cited: 11
Aminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data
Márton Vass, Sabina Podlewska, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 8, pp. 3784-3839
Open Access | Times Cited: 66
Uncovering patterns of atomic interactions in static and dynamic structures of proteins
AJ Venkatakrishnan, Rasmus Fonseca, Karen Anthony, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 57
Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies
Andrew J. Haak, Merrick T. Ducharme, Ana M. Diaz Espinosa, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 3, pp. 172-182
Open Access | Times Cited: 55
Classification Model for the Second Extracellular Loop of Class A GPCRs
Alessandro Nicoli, Andreas Dunkel, Toni Giorgino, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 3, pp. 511-522
Closed Access | Times Cited: 31
Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics
Tian‐Hua Wei, Meng‐Yi Lu, Sihui Yao, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Nucleoside analogue activators of cyclic AMP-independent protein kinase A of Trypanosoma
Sabine Bachmaier, Yuri Volpato Santos, Susanne Krämer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Strategies for the discovery of biased GPCR ligands
Marcel Bermúdez, Trung Ngoc Nguyen, Christian Omieczynski, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 4, pp. 1031-1037
Closed Access | Times Cited: 46
Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance
Shan‐Liang Sun, Shi-Han Wu, Ji-Bo Kang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7415-7437
Closed Access | Times Cited: 27
Dynamic chemical modifications and chemical interventions of G protein-coupled receptor
Ping Xu, Jingying Hu, Yuting Gao, et al.
Scientia Sinica Chimica (2025)
Closed Access
Adrenergic receptor subtypes differentially influence acrolein-induced ventilatory, vascular leakage, and inflammatory responses
Devin I. Alewel, Stephen H. Gavett, Katherine M. Rentschler, et al.
Toxicology and Applied Pharmacology (2025), pp. 117303-117303
Closed Access
Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors
Madhu Chaturvedi, Justin Schilling, Alexandre Beautrait, et al.
Trends in Biochemical Sciences (2018) Vol. 43, Iss. 7, pp. 533-546
Open Access | Times Cited: 39
‘Crystal’ Clear? Lysophospholipid Receptor Structure Insights and Controversies
Victoria A. Blaho, Jerold Chun
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 11, pp. 953-966
Open Access | Times Cited: 38
<i>MiR-375</i> Inhibitor Alleviates Inflammation and Oxidative Stress by Upregulating the <i>GPR39</i> Expression in Atherosclerosis
Hui Luo, Lin Zhao, Bo Dong, et al.
International Heart Journal (2024) Vol. 65, Iss. 1, pp. 135-145
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top